CI_with has_Ingredient has_MoA has_PE has_PK may_prevent may_treat drug associated with AE Hepatic Metabolism [PK] Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] Coronary Artery Disease [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Hypercholesterolemia [Disease/Finding] Hyperlipoproteinemias [Disease/Finding] Hypertriglyceridemia [Disease/Finding] Liver Failure [Disease/Finding] atorvastatin [Chemical/Ingredient] Decreased Cholesterol Synthesis [PE] Pregnancy [Disease/Finding] ATORVASTATIN ATORVASTATIN CALCIUM C0286650 Atorvastatin calcium N0000148468 83366 48A5M73Z4Q 4020999 C11396 Ingredient 阿托伐他汀钙胶囊 <VANDF_Record>50.416^3666^Active/Master</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3666</VA_IEN><VA_Status>Active/Master</VA_Status> ATORVASTATIN CALCIUM discomfort AE pancreatitis AE hepatitis AE abdominal distension AE hypoesthesia AE peripheral neuropathy AE rash AE pruritus AE myalgia AE urticaria AE headache AE asthenia AE arthralgia AE dizziness AE edema limbs AE paresthesia AE anorexia AE abdominal pain AE chest pain AE back pain AE alopecia AE dyspepsia AE angioedema AE amnesia AE myopathy AE blood creatine phosphokinase level increased AE hyperglycemia AE allergy AE nausea AE vomiting AE constipation AE tinnitus AE myositis AE diarrhea AE erectile dysfunction AE hypoglycemia AE jaundice cholestatic AE rhabdomyolysis AE thrombocytopenia AE transaminase level increased AE weight increased AE insomnia AE